TET2 and neoplasm: In the field of oncology, an article in the journal Science found that metformin treatment protected phosphorylation at serine 99, thereby improving TET2 stability and 5-hmC levels, which in turn stabilized tumor suppressor genes, revealing an epigenetic pathway for metformin-mediated tumor suppression (Wu et al. 2018).